Table 2 Comparison of baseline data and echocardiographic parameters.

From: Left atrial epicardial adipose tissue is closely associated with left atrial appendage flow velocity in patients with nonvalvular atrial fibrillation

 

LVZ

No LVZ

P

n = 28

n = 117

Age, years

64.61 ± 9.23

59.89 ± 11.56

0.047

Male, n (%)

17 (60.71)

81 (69.23)

0.387

Body mass index, kg/m2

24.83 ± 3.22

25.26 ± 2.85

0.490

Hypertension, n (%)

12 (42.86)

52 (44.44)

0.879

Diabetes mellitus, n (%)

8 (28.57)

15 (12.82)

0.040

Congestive heart failure, n (%)

5 (17.86)

14 (11.97)

0.407

Coronary disease, n (%)

4 (14.29)

24 (20.51)

0.453

Nonparoxysmal AF, n (%)

18 (64.29)

51 (43.59)

0.049

AF duration (month)

50.80 ± 72.73

28.06 ± 51.06

0.056

LDL cholesterol, mg/dL

2.42 ± 0.87

2.33 ± 0.75

0.656

eGFR (ml/min/m2)

103.85 ± 13.95

99.58 ± 17.02

0.220

LV ejection fraction, %

59.04 ± 5.76

59.24 ± 5.93

0.870

LAVI (mL/m2)

83.42 ± 31.04

64.63 ± 20.50

 < 0.001

LA-EAT volume (cm3)

37.35 ± 12.39

29.14 ± 11.14

0.001

LAA morphology (C-W), n (%)

9(32.14)

42(35.90)

0.371

LAA flow velocity (cm/s)

35.02 ± 10.78

50.60 ± 12.17

 < 0.001

  1. LVZ, Low Voltage Zone; AF, atrial fibrillation; LDL-C, Low-density lipoprotein; LV, left ventricular; LAVI, left atrial volume index; LA, left atrial; EAT, Epicardial adipose tissue; LAA, Left atrial appendage; C-W, chicken-wing type.
Back to article page